597 / 1363
EMBRACE trial (1)
intErnational study on Mri-guided BRachytherapy in locally
Advanced CErvical cancer.
European study on MRI-guided brachytherapy in locally advanced
cervical cancer (GEC-ESTRO) started in 2008.
Accrual ended in December 2015, with > 1400 patients included.
Prospective observational multicenter setting
Primary endpoints: LC and morbidity.
Secondary endpoints: RC, DFS, OS and QoL.
Correlation between image-based DVH and outcome.
FIGO IB to IVA
EBRT + BT